3150
T. Kanger et al.
PAPER
1H NMR (CDCl3): d = 5.77 (dd, 1 H, J = 1.0, 2.2 Hz, H-3), 3.89 (dd,
1 H, J = 8.1, 9.5 Hz, H-6), 3.29 (br s, 1 H, OH), 2.78 and 2.53 (m, 2
H, H-4), 2.32 and 2.26 (each d, 2 H, J = 17.8 Hz, H-1), 2.23 and
2.03 (m, 2 H, H-5), 1.13 (s, 3 H, CH3).
MS (EI): m/z = 166 (M+), 138, 109, 95, 67.
Anal. Calcd for C9H10O3 (166.17): C, 65.05; H, 6.07. Found: C,
64.99; H, 6.16.
13C NMR (CDCl3): d = 210.69 (C-2), 192.32 (C-3a), 125.24 (C-3),
77.57 (C-6), 53.23 (C-6a), 49.57 (C-1), 31.85 (C-5), 23.99 (C-4),
18.42 (CH3).
(1aS*,3aS*,4R,6aS*)-4-Hydroxy-3a-methyltetrahydro-1aH-
pentaleno[1,6a-b]oxiren-2(3H)-one (11)
To a solution of enone 8 (108 mg, 0.71 mmol) in MeOH (7 mL),
was added 33% H2O2 (0.19 mL, 2.13 mmol) at r.t., followed by
dropwise addition of aq 5 M NaOH (0.035 mL, 0.18 mmol). After
stirring for 1 h, the mixture was poured into brine (10 mL) and ex-
tracted with EtOAc (5 × 10 mL). The combined organic phases were
dried (MgSO4) and evaporated. The residue was purified by column
chromatography (10% acetone in petroleum ether), to afford a yel-
low oil; yield: 95 mg (80%).
MS (EI): m/z (%) = 152 (M+, 12), 124 (63), 109 (100), 79 (71).
Anal. Calcd for C9H12O2 (152.19): C, 71.03; H, 7.95. Found: C,
70.38; H, 8.06.
(6R*,6aR*)-3-Benzyl-6-hydroxy-6a-methyl-4,5,6,6a-tetrahy-
dropentalen-2(1H)-one (9)
A suspension of NaH (9.2 mg, 0.23 mmol) in THF (3 mL) was
cooled in an ice-bath under argon. A solution of enone 8 (105 mg,
0.69 mmol) in THF (4 mL) was added dropwise and the mixture
was stirred for 30 min. A second portion of NaH (9.2 mg, 0.23
mmol) was added and after another 30 min, a third portion of NaH
(9.2 mg, 0.23 mmol) was added. The mixture was stirred for addi-
tional 30 min followed by addition of benzyl bromide (0.16 mL,
1.38 mmol). The mixture was stirred for 4 h at 0 °C and for over-
night at r.t. After addition of H2O (20 mL), the mixture was extract-
ed with EtOAc (4 × 20 mL). The combined organic phases were
dried (MgSO4) and the solvent was evaporated. The residue was pu-
rified by column chromatography (10% EtOAc in petroleum ether)
affording a yellow oil; yield: 67 mg (40%).
IR (film): 3419, 2970, 1743, 1248, 1097, 1070, 1048, 883 cm–1.
1H NMR (CDCl3): d = 3.88 (t, 1 H, J = 8.5 Hz, H-4), 3.21 (s, 1 H,
H-1), 2.37 (d, 1 H, J = 19.0 Hz, H-3), 2.33 (m, 1 H, H-6), 2.27 (m,
1 H, H-5), 2.18 (br s, 1 H, OH), 2.04 (d, 1 H, J = 19.0 Hz, H-3), 1.88
(m, 2 H, H-5,6), 1.13 (s, 3 H, CH3).
13C NMR (CDCl3): d = 209.47 (C-2), 75.98 (C-4), 75.80 (C-6a),
62.77 (C-1), 44.98 (C-3a), 44.84 (C-3), 29.65 (C-5), 20.93 (C-6),
13.28 (CH3).
MS (EI): m/z = 168 (M+), 139, 124, 95, 69.
(3aR*,6aR*)-5-Hydroxy-6a-methyl-2,3,3a,6a-tetrahydropen-
talene-1,4-dione (12)
IR (film): 3411, 3028, 2966, 1698, 1652, 1603, 1495, 1083, 1041,
705 cm–1.
To a solution of epoxide 10 (53 mg, 0.32 mmol) in benzene (5 mL),
was added BF3·OEt2 (40 mL, 0.32 mmol). The resulting mixture was
refluxed for 2 h. After addition of aq sat. NaHCO3 solution (10 mL),
the mixture was extracted with EtOAc (6 × 5 mL), and the com-
bined organic layers were dried (MgSO4) and evaporated. The resi-
due was purified by column chromatography (20% acetone in
petroleum ether) to give 12; yield: 34 mg (64%).
1H NMR (CDCl3): d = 7.28 (t, 2 H, J = 7.4 Hz, meta-Harom), 7.21 (t,
1 H, J = 7.4 Hz, para-Harom), 7.18 (d, 2 H, J = 7.4 Hz, ortho-Harom),
3.89 (dd, 1 H, J = 8.1, 9.5 Hz, H-6), 3.56 (d, 1 H, J = 15.3 Hz,
PhCH2), 3.43 (dd, 1 H, J = 1.1, 15.3 Hz, PhCH2), 2.54 (m, 1 H, H-
4), 2.37 and 2.34 (d each, 2 H, J = 17.7 Hz, H-1), 2.35 (br s, 1 H,
OH), 2.33 (m, 1 H, H-4), 2.22 and 2.00 (m each, 2H, H-5), 1.15 (s,
3 H, CH3).
13C NMR (CDCl3): d = 209.11 (C-2), 184.62 (C-3a), 138.81 (Carom),
135.83 (C-3), 128.55 (o-CHarom), 128.41 (m-CHarom), 126.11 (p-
CHarom), 78.10 (C-6), 51.14 (C-6a), 48.99 (C-1), 32.11 (C-5), 29.63
(PhCH2), 22.93 (C-4), 18.66 (CH3).
IR (KBr): 3151, 2974, 2932, 1739, 1690, 1608 cm–1.
1H NMR (CDCl3): d = 6.32 (s, 1 H, H-6), 2.73 (m, 1 H, H-3a), 2.43
and 2.25 (m, 2 H, H-2), 2.14 and 2.15 (m, 2 H, H-3), 1.13 (s, 3 H,
CH3).
1H NMR (DMSO-d6): d = 9.99 (s, 1 H, OH), 6.13 (s, 1 H, H-6), 2.68
(d, 1 H, J = 8.7 Hz, H-3a), 2.41 and 1.90 (m, 2 H, H-2), 2.11 and
2.10 (m, 2 H, H-3), 1.23 (s, 3 H, CH3).
MS (EI): m/z = 242 (M+), 214, 196, 181, 91, 77.
Anal. Calcd for C16H18O2 (242.31): C, 79.31; H, 7.49. Found: C,
78.81; H, 7.55.
13C NMR (CDCl3): d = 215.67 (C-1), 205.41 (C-4), 153.21 (C-5),
132.32 (C-6), 52.49 (C-3a), 51.76 (C-6a), 35.20 (C-2), 20.15 (C-3),
19.62 (CH3).
13C NMR (DMSO-d6): d = 216.49 (C-1), 204.89 (C-4), 154.56 (C-
5), 131.40 (C-6), 52.21 (C-3a), 50.84 (C-6a), 34.90 (C-2), 19.78 (C-
3), 19.66 (CH3).
(1aS*,3aR*,6aS*)-3a-Methyltetrahydro-1aH-pentaleno[1,6a-
b]oxirene-2,4-dione (10)
To a solution of enone 2 (1.46 g, 9.74 mmol) in THF (50 mL), was
added a solution of H2O2 (33% in H2O, 1.77 mL, 19.47 mmol) at
0 °C, followed by dropwise addition of 0.1 M NaOH (48.70 mL,
4.87 mmol). After stirring for 2 h, the mixture was poured into a so-
lution of brine (100 mL) and extracted with EtOAc (5 × 50 mL). The
combined organic phase were dried (MgSO4) and evaporated. The
residue was purified by column chromatography (10% acetone in
petroleum ether), affording the target compound as white crystals;
yield: 938 mg (58%).
MS (EI): m/z = 166 (M+), 138, 120, 110, 95.
Anal. Calcd for C9H10O3 (166.17): C, 65.05; H, 6.07. Found: C,
65.01; H, 6.10.
(3aR*,4R*,6aR*)-2,4-Dihydroxy-3a-methyl-4,5,6,6a-tetrahy-
dropentalen-1(3aH)-one (13)
A mixture of epoxide 11 (40 mg, 0.24 mmol) and 0.01 M H2SO4
(5.5 mL) was heated at 100 °C for 24 h. The mixture was cooled and
extracted with EtOAc (4 × 5 ml). The EtOAc extract was dried
(MgSO4) and evaporated. The residue was purified by column chro-
matography (25% acetone in petroleum ether), affording a yellow
solid; yield: 18 mg (45%).
IR (KBr): 3066, 2944, 2924, 1753, 1735, 1125, 1057, 1002 cm–1.
1H NMR (CDCl3): d = 3.34 (s, 1 H, H-1), 2.88 (ddd, 1 H, J = 1.9,
10.5, 19.4 Hz, H-5), 2.69 (ddd, 1 H, J = 9.6, 10.5, 13.6 Hz, H-6),
2.67 (d, 1 H, J = 19.7 Hz, H-3), 2.52 (ddd, 1 H, J = 9.5, 9.6, 19.4 Hz,
H-5), 2.17 (ddd, 1 H, J = 1.9, 9.5, 13.6 Hz, H-6), 2.10 (d, 1 H,
J = 19.7 Hz, H-3), 1.25 (s, 3 H, CH3).
13C NMR (CDCl3): d = 213.91 (C-4), 206.36 (C-2), 75.41 (C-6a),
61.84 (C-1), 48.74 (C-3a), 42.69 (C-3), 36.72 (C-5), 21.04 (C-6),
16.85 (CH3).
IR (KBr): 3417, 3108, 2963, 2932, 1695, 1649, 1422, 1220, 1103,
966 cm–1.
Synthesis 2005, No. 18, 3147–3151 © Thieme Stuttgart · New York